Market cap
$1,020 Mln
Revenue (TTM)
$202 Mln
P/E Ratio
358.7
P/B Ratio
13.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.46 | 13.88 | 15.51 | 21.76 | 27.85 |
| EBIT | -- | -- | 130.98 | 26.33 | -- |
| Net Profit | -91.98 | -79.77 | -67.24 | 26.12 | -25.92 |
| EPS | -91.49 | -80.84 | -66.29 | 26.12 | -- |
| Book Value | -- | -- | 34.55 | -5.27 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -0.64 | -60.16 | -- | 6.85 | -8.13 |
| Net Margin
| -8.86 | -8.86 | -- | -- | -8.86 |
| Return on equity
| -2.48 | 61.38 | 4.45 | 10.15 | -22.05 |
| Return on Capital
| -2.94 | 139.16 | 3.47 | 8.54 | -20.84 |
| Return on Assets
| -1.37 | -75.98 | 2.24 | 5.18 | -11.54 |
| Debt to Equity (x)
| -- | -- | 0.28 | 0.29 | 0.11 |
Profitability
ROCE
3.47
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
3.47
|
8.54
|
-20.84
|
708.23
|
-3.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
4.45
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
4.45
|
10.15
|
-22.05
|
316.65
|
-2.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
2.24
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
2.24
|
5.18
|
-11.54
|
-388.81
|
13.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
6.85
|
-8.13
|
-246.99
|
7.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
1.40
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
1.40
|
3.45
|
-8.86
|
-252.68
|
5.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.16
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
0.16
|
0.16
|
0.35
|
0.40
|
0.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
197.77
|
95.57
|
-4,642.05
|
-56.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-53.15
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
-53.15
|
145.43
|
95.30
|
-7,050.06
|
-67.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.54
--
Year on year growth in earnings per share
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
-0.54
|
1.47
|
0.97
|
-54.54
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.28
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
0.28
|
0.29
|
0.11
|
--
|
-0.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.08
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
0.08
|
0.08
|
0.12
|
--
|
-0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.42
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
3.42
|
3.44
|
5.57
|
11.06
|
2.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
--
|
5.22
|
11.06
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
7.28
|
-29.59
|
-60.05
|
3.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
15.87
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
15.87
|
16.08
|
17.20
|
16.31
|
15.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
1.60
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
1.60
|
1.50
|
1.31
|
1.54
|
2.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
54.40
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
54.40
|
56.42
|
53.54
|
49.71
|
48.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
38.69
|
23.67
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
8.67
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
8.67
|
12.35
|
16.34
|
17.27
|
7.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
--
|
82.76
|
60.88
|
32.43
|
40.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
472.71
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
472.71
|
205.70
|
-96.93
|
-6.17
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
18.22
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
18.22
|
23.09
|
19.78
|
31.50
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
211.26
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
211.26
|
55.58
|
-218.87
|
-6.17
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|